Double Bond Pharma signs agreement for distribution of Pharysol

Double Bond Pharmaceutical (DBP) and Vitro-Bio have today signed an agreement for distribution of Pharysol in Sweden, Norway and Denmark. The distribution will be held through Drugsson AB. "In line with our goal to build a self-sustaining pharmaceutical company with a balanced portfolio consisting of both innovative development products and ready-to-sell unique products we are very pleased to be able to expand our collaboration with Vitro-Bio in terms of distribution of broader line of their products. Pharysol is a treatment against common cold and expected to bring the largest revenue